Anixa Biosciences, Moffitt Cancer Center, ovarian cancer, CAR-T cell therapy, liraltagene autoleucel, lira-cel, CER-T technology, FSHR-targeted therapy, cancer immunotherapy

San Jose, California, U.S., October 26, 2026 Anixa Biosciences, Inc. has announced the completion of treatment in the fifth...